Drug Latebreakers

Results of a 16-week trial of insulin aspart

Bendamustine has been approved by the FDA for the treatment of CLL

Medicare Part B has expanded coverage for warfarin patients monitoirng clotting time at
home.

CMS will require Medicare Advantage annd prescription drug plan sponsors in the Medicare Part D
program, cover more HIV retrovirals, include more MTM data, and specify prior authorization
requirements.

American Pharmacists Association and the NACDS Foundation launch MTM Version 2.0, an improved model
for medication therapy management programs.

The feds have released the pricing for durable medical equipment, prosthetics, orthotics, and supplies
for the first round of competitive bidding

CVS Caremark has reached a settlement agrement with Department of Jutice to resolve an investigation
into the practice of dispensing the generic ranitidine in capsule rather than tablet form

Walgreens is launching health and wellness division to expand into worksite health clinics and has
acquired two companies, I-trax and Whole Health Management of Cleveland.

The Centers for Medicare and Medicaid Services has issued a new definition of multi-source
drugs

USA Today series draws attention to the role of technicians and corporate policies in contributing to
medication errors at chain pharmacies.